# FDA Inspection 1091860 - IntegReview, Inc. IRB - May 22, 2019

Source: https://www.keypedia.com/records/fda_inspections/integreview-inc-irb/b292207b-f15d-432c-8001-c56fed4309cd
Source feed: FDA_Inspections

> FDA Inspection 1091860 for IntegReview, Inc. IRB on May 22, 2019. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1091860
- Company Name: IntegReview, Inc. IRB
- Inspection Date: 2019-05-22
- Classification: No Action Indicated (NAI)
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 831718 - 2013-05-15](https://www.keypedia.com/records/fda_inspections/integreview-inc-irb/10adcea2-dec0-4ca3-8874-fc3fec10a469)
- [FDA Inspection 607367 - 2009-07-31](https://www.keypedia.com/records/fda_inspections/integreview-inc-irb/c6530cc6-ad52-4f0e-822c-2836be85d198)

Company: https://www.keypedia.com/companies/integreview-inc-irb/649f78b1-386d-4886-850d-96d2acd8d9c3

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c